At ZYP Medical , we offer customized weight loss plans that include GLP-1 compounded medications , such as semaglutide and tirzepatide
In summary, 2025 marks a turning point in MPNST research, with precision oncology, immunotherapy combinations, and early detection technologies offering hope in a disease long defined by limited treatment options and poor outcomes
If you notice any odd symptoms such as ongoing nausea, serious allergic reactions, or signs of thyroid cancer, please speak to your healthcare provider right away
The long-acting GLP-1 agonists segment held the largest market share of 63% in 2025, driven by the offering of once-weekly dosing, which drastically enhances patient adherence over daily therapies
Some medications can interact or compound dizziness